Dr. Reddy's Laboratories Stock (NSE:DRREDDY)


INR 4,002.00
Today's Range
INR3,967.00 - INR4,135.40
52-Week Range
INR3,654.00 - INR5,574.39
Market Cap

About Dr. Reddy's Laboratories (NSE:DRREDDY)

(NSE:DRREDDY) Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosage with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. It also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Proprietary Products segment focuses on the research, development, and manufacture of differentiated formulations for dermatology and neurology therapeutic areas. The company also engages in developing therapies in the fields of oncology and inflammation. As of March 31, 2020, it had four late stage projects at various stages of development. The company's therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. It has collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists; and partnership with Department of Biotechnology - Biotechnology Industry Research Assistance Council for Sputnik V vaccine clinical trials in India. The company was founded in 1984 and is headquartered in Hyderabad, India.
Show more

DRREDDY Stock Price

Statistics Highlights (NSE:DRREDDY)

Shares Outstanding 165.96M Beta 0.15
Public Float 117.35M P/E Ratio 25.31
% Short of Float - Dividend (Yield) 25.00 (0.01%)
Held by Insiders 8.21% Ex-Dividend Date Jul 12, 2021
Held by Institutions 57.32% IPO Date -

DRREDDY Financial Summary

Mar 21 Mar 20 Mar 19
Revenue INR189.72B INR174.60B INR153.85B
EBITDA INR40.18B INR31.49B INR35.52B
Net Income INR17.24B INR19.50B INR18.80B
Total Assets INR265.49B INR232.24B INR225.43B
Total Cash INR14.83B INR2.05B INR2.23B
Total Debt INR30.31B INR22.10B INR38.38B
Dec 21 Sep 21 Jun 21
Revenue INR53.38B INR57.63B INR49.19B
EBITDA INR12.90B INR15.90B INR10.52B
Net Income INR7.09B INR9.92B INR5.71B
Total Assets INR282.50B INR278.50B INR278.21B
Total Cash INR21.98B INR9.98B INR8.17B
Total Debt INR INR30.27B INR33.37B

DRREDDY Stock Price History

Dr. Reddy's Laboratories Annual Stock Price History

Year Open Close Change
2021 INR4904.00 INR4002.00 -18.39%
2021 INR5217.25 INR4904.00 -6.00%
2020 INR2890.00 INR5217.25 80.53%

Dr. Reddy's Laboratories Daily Stock Price History

Date Open High Low Close Change Volume
Jun 9, 2022 INR4170.10 INR4335.00 INR4170.10 INR4322.90 1.46% 740.57K
Jun 22, 2022 INR4281.00 INR4348.85 INR4160.00 INR4260.90 -0.15% 569.55K
Jun 13, 2022 INR4323.00 INR4355.00 INR4256.50 INR4267.20 -0.90% 367.91K

(NSE:DRREDDY) Stock Price FAQs

What is today's stock price of Dr. Reddy's Laboratories (NSE:DRREDDY)?

  • The current stock price of Dr. Reddy's Laboratories (NSE:DRREDDY) is INR4002.00.
  • Today DRREDDY stock price opened at INR4124.00 after previous close of INR4123.90.
  • During the day, Dr. Reddy's Laboratories stock quote has varied from a low of INR3967.00 to a high of INR4135.40.

What is Dr. Reddy's Laboratories's 52-week change?

  • DRREDDY 52-week high stock quote is INR5574.39, which is 39.30% above the current share price.
  • The Dr. Reddy's Laboratories (NSE:DRREDDY) 52-week low stock price is INR3654.00, which is 8.70% below the current share price.
  • Dr. Reddy's Laboratories share price volatility (52-week beta) is 0.15.

Dr. Reddy's Laboratories (NSE:DRREDDY) FAQ

How Much is Dr. reddy's laboratories Worth?

Dr. reddy's laboratories's worth today based on market capitalisation is INR664.81B

How much dividend does Dr. reddy's laboratories Pay?

The current annualized dividend payout for DRREDDY stock is INR25.00, the dividend yield is 0.61% and the payout ratio is 15.79%.
View More Details on Dr. reddy's laboratories's "Dividend" Section

What is Dr. reddy's laboratories’s Price to Earning (PE) ratio?

Dr. reddy's laboratories has a Price to Earning (P/E) ratio of 25.31. DRREDDY stock also has a Price to Sales (P/S) ratio of 3.21, a Price to Book of 3.61 and Price/Earnings to Growth (PEG) of 1.12.

What is the Dr. reddy's laboratories's ticker?

Dr. reddy's laboratories trades on the NSE stock market in India under the ticker symbol "DRREDDY". Dr. reddy's laboratories’s stock symbol can also be displayed as "NSE:DRREDDY".

Who are the owners of Dr. reddy's laboratories?

Dr. reddy's laboratories (NSE:DRREDDY) is owned by 57.32% institutional shareholders and by 8.21% insiders. The rest is owned by the public.
Explore More Details on Dr. reddy's laboratories's “Ownership” Section

Who are the key executives of Dr. reddy's laboratories (DRREDDY)?

Dr. reddy's laboratories's key executive team includes the following managers:

  • Mr. Gunupati Venkateswara Prasad B.E., Co-Chairman, MD & Member of Management Council (1960)
  • Mr. Kallam Satish Reddy, Chairman & Member of the Management Council (1967)
  • Mr. Erez Israeli M.B.A., CEO & Member of the Management Council (1968)
  • Mr. Parag Agarwal, CFO & Member of Management Council (NA)
  • Mr. Deepak Sapra M.B.A., CEO of API & Services & Member of Management Council (1975)
  • Mr. Venkata Ramana Motupalli M.B.A., MBA, CEO of Branded Markets - India & Emerging Countries and Member of Management Council (1969)
  • Ms. Archana Bhaskar B.Sc., M.B.A., EVP, Head of Corp. Communications, Chief HR Officer & Member of Management Council (1967)
  • Mr. Sanjay Sharma B.Tech., Exec. VP, Global Head of Global Manufacturing & Member of Management Council (1968)
  • Mr. Marc Kikuchi B.A., M.B.A., CEO of North America Generics & Member of Management Council (1969)
  • Mr. Patrick Aghanian B.A., M.B.A., CEO of European Generics & Member of Management Council (1965)

What is Dr. reddy's laboratories’s Sector & Industry Classification?

Dr. reddy's laboratories (NSE:DRREDDY) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.

What is the ESG rating for Dr. reddy's laboratories (NSE:DRREDDY) ?

ESG scores assess the degree to which a company’s enterprise business value is at risk driven by environmental, social, and governance issues. The scores are a measure of risk on an absolute scale of 0-100, with a lower score meaning less risk.

DRREDDY’s total ESG score is 36.19. The company’s environmental score is 1.80, social score is 21.16 and governance score is 13.33.
Dr. reddy's laboratories (NSE:DRREDDY) is involved in the following activities (which decreases its ESG score) : "animalTesting".

How many employees work for Dr. reddy's laboratories?

Currently the number of employees working for Dr. reddy's laboratories is 22,739.

Where are Dr. reddy's laboratories's Headquarters?

Dr. reddy's laboratories (NSE:DRREDDY) is headquartered in India.

What are Dr. reddy's laboratories's Address and Phone Number?

Dr. reddy's laboratories’s mailing address is 8-2-337, Road No. 3, Hyderabad, India, 500034.
The company’s phone number is 91 40 4900 2900.

What is the official website for Dr. reddy's laboratories?

Dr. reddy's laboratories’s official website is http://www.drreddys.com